Skip to content

News Hub

The latest breaking stories

Access up-to-date news and information on a wide range of press releases including business, finance, technology, healthcare, entertainment, and more.

NewsMatch Alert

Discover the most important & comprehensive stories delivered directly to you daily.

  • Technology Innovation
  • 27/02/2026
  • 00:11
NTT DATA

NTT DATA and Ericsson Team Up to Scale Private 5G and Physical AI for Enterprises

Private 5G delivered as a fully managed global service with consistent security and operations worldwide Edge AI and physical AI embedded directly into enterprise…

  • Contains:
  • Technology Innovation
  • 26/02/2026
  • 23:11
Amazfit

Amazfit Introduces the Active 3 Premium: Turning Daily Movement into Meaningful Progress for Entry-Level Runners

Premium materials, a 12-day battery life and new running features provide support for those kicking off their running journey MILPITAS, Calif.–BUSINESS WIRE– Amazfit, a…

  • Contains:
  • Sport Recreation
  • 26/02/2026
  • 23:11
U.S. Polo Assn.

U.S. Polo Assn. Returns as Official Apparel and Jersey Sponsor of the 2026 Dubai Polo Gold Cup for Third Consecutive Year

WEST PALM BEACH, FL AND DUBAI, UAE / ACCESS Newswire / February 26, 2026 / U.S. Polo Assn., the official sports brand of the…

  • Contains:
  • RetailOnline Retail
  • 26/02/2026
  • 23:11
LotusFlare

PNCC Selects LotusFlare to Power Digital BSS and Commerce Platform for New 4G/5G Standalone Network

SANTA CLARA, Calif.–BUSINESS WIRE– LotusFlare, a provider of a cloud-native, AI-driven digital commerce and monetization platform for communications service providers (CSPs), today announced that…

  • Contains:
  • Medical Health Aged Care
  • 26/02/2026
  • 23:11
Kairos Pharma, Ltd

Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics

Transformative clinical pipeline transaction will add CL-273, a pan-EGFR inhibitor, and CL-741, a Phase 1-Ready c-MET inhibitor, to Kairos Pharma's clinical portfolio to target multi-billion dollar lung cancer market. LOS ANGELES--BUSINESS WIRE--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces the signing of a term sheet for a strategic asset acquisition with Celyn Therapeutics, Inc., a privately held biotechnology company backed by OrbiMed and Torrey Pines Investment. Under the proposed terms of the agreement, Kairos Pharma will acquire worldwide rights to two highly differentiated, clinical-stage oncology assets targeting non-small cell lung cancer…

  • Property Real Estate
  • 26/02/2026
  • 22:41
Neinor Homes, SA

Neinor records €122mn FY25 Net Income after executing largest M&A in Spanish Residential of the last decade

MADRID, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Neinor Homes (“Neinor”) closed FY25 with standout operational and financial results. During FY25 and excluding the impact from acquiring a 79.2% stake in AEDAS, Neinor has notarized a total of 2,901 housing units, of which 1,891 corresponded to the fully owned portfolio and 1,010 to the Asset Management business. Total revenues for 2025 reached €697mn.Borja García-Egotxeaga, CEO of Neinor Homes,commented: “This was a transformational year for Neinor. We outperformed operationally, strengthened our balance sheet and closed the largest residential transaction in Spain in over a decade, creating the undisputed national champion. At a…

  • General News
  • 26/02/2026
  • 22:33
The Publicity Department of the CPC Fuzhou Municipal Committee

Fuzhou Debuted Global Video Campaign “Welcome to Fuzhou For A Happy Chinese New Year”

FUZHOU, China, Feb. 26, 2026 /Xinhua-AsiaNet/– From the festive beauty of intangible cultural heritage, to the popularity of red tourism landmarks, the diversity of…

  • Medical Health Aged Care
  • 26/02/2026
  • 22:12
BeOne Medicines Ltd.

BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership

Total global revenues of $1.5 billion and $5.3 billion for the fourth quarter and full year, increases of 33% and 40% from the prior-year…

  • Contains:
  • Transport Automotive
  • 26/02/2026
  • 20:40
DENZA

DENZA Opens First South Australian Showroom in Adelaide

ADELAIDE, Australia, Feb. 26, 2026 (GLOBE NEWSWIRE) -- On 13 February 2026, DENZA officially opened its first showroom in South Australia, marking another step in the brand's expansion across Australia. The launch in Adelaide signals the continued growth of the premium new energy brand and the increasing global presence of Chinese intelligent manufacturing.More than 150 guests attended the opening ceremony, including representatives from government, business and media, along with DENZA VIP customers. Guests included Wing You, General Manager of BYD Australia and New Zealand; Brian Jia, Deputy General Manager of BYD Australia and New Zealand; Mark Harland, Chief Operating Officer…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.